Research Associate 

Computational Biology

Director, Spaceflight Research/Mason Lab

Weill Cornell Medical College

​Staff Scientist; Fellowship Mentor

Bioastra

​

A spaceflight multi-omics leader, Dr. Kim is Director of Spaceflight Research at Weill Cornell's Mason Lab. He studies molecular adaptations to space and advances personalized medicine, contributing to the Space Omics Medical Atlas and supporting missions including Inspiration4 and Axiom-2.

His research builds at the intersection of biology and AI. At Weill Cornell Medicine, Dr. Kim has worked on computational research spanning multi-omics across six commercial spaceflight missions, including Inspiration4, Polaris Dawn, and Fram2. This work contributed to the 40-paper SOMA package published in Nature Publishing Group journals, a collaboration spanning 100+ institutions in 25+ countries. Two patents from his work on epilepsy and cancer therapeutics have been successfully licensed, with milestone payments achieved. Increasingly, my work lives at the frontier of AI and science. Dr. Kim builds evaluation systems that test whether AI actually understands biology: 7+ benchmark frameworks, 900+ tasks spanning biology, bioinformatics, and peer review. He curates large-scale datasets (101K+ structured peer review concerns, 32.8M negative results) and closes the loop from evaluation to training to deployed models. He also led the first Perturb-seq experiment conducted in space: 105K cells and 928 genes. Dr.Kim serves as a peer reviewer for journals, including Nature Communications, and as a judge for NASA Human Research Program meetings. 

 

(Source: Weill Cornell Medicine and speaker bio)